Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
HYPOTHESIS:
4.
H 1:
H 2:
anomalies and imply a failure of proper closure of neural tube and covering
mesoderm and ectoderm.
Periconceptional period: Periconceptional period is period start from first three
month before conception and after three month of conception.
INTRODUCTION
Mother is one who nurtures us in her womb 9 months and bring us to enjoy
the supreme blessing on earth, that is life. A women, pregnancy and motherhood
are developmental milestones that are highly emphasized by our culture.
Motherhood traditionally has been considered almost a sacred state and the only
way for women to fulfill herself. 1
Birth defects are also called "congenital anomalies or "congenital
abnormalities." The word "congenital" means "present at birth." The words
"anomalies" and "abnormalities" mean that there is a problem present in a baby. 2
World health statistics 2008; about 260,000 national deaths world wide
cased by congenital anomalies. This figure reported about 71 percentage of the
neonatal death. 3
Neural tube defects (NTDs) are among the most common birth defects that
cause infant mortality (death) and serious disability. 3
Periconceptional period is the period from first three months before
conception and after three month of conception. Adequate folate intake during the
Periconceptional period, the time just before and just after a women become
A wide range of frequency has been quoted from different parts of India &
it was 3.9/1000 in Lucknow, 7/1000 in last Delhi and 11.4/1000 birth
in
Davangere(Karnataka). 6
There are many factors that cause Neural Tube Defects in newborns. The
cause of NTDs is not known. Scientists believe that there are genetic factors,
environmental factors, and nutritional components. However, according to the
March of Dimes, the parents of about 95% of babies born with NTDs do not have a
family history of these disorders. 3
Primary NTDs have multifactorial inheritance maternal risk factors include
alcohol, radiation exposure, insulin dependent diabetes mellitus (IDDM), Valproate
and carbamazepene, zinc, vitamin B, vitaminB12, vitamin C and folate deficiency.
Chromosomal abnormality including Trisomy 13 and 15 has been reported. 7
Maternal malnutrition is an important risk factor for development of Neural
tube defect. lack of Periconceptional folic acid supplementation, folate poor diet ,
related lack of education in nutrition , poverty , poor eating habits , prolonged
cooking of vegetables and cultural factors (food-fads) etc. are the important risk
factors. 8
Foods that are high in folic acid include kiwi fruits and papaya, vegetables
such as brocolli, brussell sprouts, spinach, cabbage, asparagus and cooked kidney.
Be careful not to overcook your vegetables as this may destroy the folic acid. Other
good sources of folic acid include baked beans, lettuce. Oranges, egg yolks, milk
and peas.8
Indian Academy of pediatric (IAP) recommended that all women capable of
becoming pregnant consume 400 microgram of folic acid daily prevent NTDs
.Studies prove that periconceptional folic acid supplementation can prevent 60% or
more such as Spina bifida and anencephaly . 9
The studies reported that women periconceptional consuming vitamin
supplement pills containing folic acid an urgently needed to prevent birth defect,
compliment to the folic acid fortification of cereal grains and other studies suggest
that substantial educational campaign could, over a few years period double the
number of women consuming folic acid supplement pills and make substantial
contribution towards preventing Spina bifida and Anencephaly. 10
The studies report have been increases in folic acid awareness and
knowledge, since most women of child bearing age still dont consume the
recommended amount of folic acid daily for prevention of NTDs . Awareness of
folic acid among women 18-25 years of age has increase from 52 percentage in
1995 to about 84 percentage in 2005 and knowledge of folic acid has increased
from 4 percentage to 19 percentage in the same time.10
The Centers for Disease Control and prevention (CDC) estimate that 50
percentage to 70 percentage of all NTDs can be prevented with the maternal
periconceptional consumption of the Vitamin B, folic acid (CDC2001). The
Institutes Medicine CDC recommended the maternal consumption of 400
micrograms of synthetic folic acid daily 1 month before conception and during the
first few months of pregnancy. Because half of the all pregnancy in the United
States are unplanned (Finces and Henshow 2006) and because NTDs occur often
before a women knows she is pregnant. CDC recommends that all women who can
become pregnant consume the recommended amount of folic acid daily, regardless
of their pregnancy intervention. 11
rarely be an isolated problem (caused by mutations in the TSH subunit gene), but
most commonly it is associated with other pituitary hormone deficiencies, as part
of congenital hypopituitarism. Peripheral hypothyroidism is a separate category
resulting from defects of thyroid hormone transport, metabolism, or action.
Congenital hypothyroidism is classified into permanent and transient CH.
Permanent CH refers to a persistent deficiency of thyroid hormone that requires
life-long treatment. Transient CH refers to a temporary deficiency of thyroid
hormone, discovered at birth, but then recovering to normal thyroid hormone
production. Recovery to euthyroidism typically occurs in the first few months or
years of life. Permanent CH can be further classified into permanent primary and
secondary (or central) CH; transient primary CH has also been reported. In
addition, some forms of CH are associated with defects in other organ systems;
these are classified as syndromic hypothyroidism.
The underlying etiology of CH typically will determine whether hypothyroidism is
permanent or transient, primary, secondary, or peripheral, and whether there is
involvement of other organ systems (see section on Etiology for details). The
primary emphasis of this review is a discussion of primary CH, but there also will
be some discussion of secondary or central CH. It should be borne in mind that an
underlying etiology may not be determined for many cases of CH. Further, while
the exact cause of some cases of thyroid dysgenesis is known, e.g., a mutation in
the TTF-2 gene, mutations in genes encoding such transcription factors important
in thyroid gland development have been found in only 2% of cases. Thus, an exact
cause for the vast majority of cases of thyroid dysgenesis remains unknown. This
has not been a significant issue, however, as management of CH is based on
restoring thyroid function to normal, not necessarily knowing the exact underlying
cause.
Epidemiology
the Greek Cypriot population over an 11 year period found the incidence in
newborns to be 1:800 [4].
A recent report showed that the incidence in the United States increased from
1:4,094 in 1987 to 1:2,372 in 2002 [5]. The reason(s) for the increased incidence is
not clear, but one possible explanation may be a change in testing strategy. With
increased sensitivity and accuracy of TSH methods, many U.S. and other programs
around the world have switched from a primary T4-follow-up TSH approach to a
primary TSH test. If the TSH cutoff is lowered, more infants with milder
congenital hypothyroidism will be detected. In addition, there is some variation in
the incidence among different racial and ethnic groups, and the mix of these groups
has changed. Several U.S. programs have reported a higher incidence in the Asian,
Native American, and Hispanic populations and lower in the American Black
population as compared to the White population. A summary of the New York
State program during the years 2000 to 2003 showed some interesting
demographic variations in the incidence of congenital hypothyroidism (see Table
Table1)1) [5]. As compared to the overall incidence of congenital hypothyroidism,
the incidence was somewhat lower in Whites (1:1815) and Blacks (1:1902),
somewhat higher in Hispanics (1:1559), and highest in the Asian population
(1:1016). In addition, New York found the incidence nearly double in twin births
(1:876) as compared to singletons (1:1765), and even higher with multiple births
(1:575). Older mothers (> 39 years) had a higher incidence (1:1,328) compared to
younger mothers (< 20 years, 1:1,703). The incidence was higher in preterm vs.
term infants [5]. It is not clear whether that the congenital hypothyroidism in
preterm infants is transient or permanent. However, as the incidence of preterm
births has increased by approximately 20 percent over the last 20 years, this may
contribute to the reported overall increased incidence. Nearly all screening
programs report a female preponderance, approaching 2:1 female to male ratio [6].
A report from Quebec shows this female preponderance occurs mostly with thyroid
ectopy, and less so with agenesis [7].
Clinical description
The clinical features of congenital hypothyroidism are often subtle and many
newborn infants remain undiagnosed at birth [8,9]. This is due in part to passage of
maternal thyroid hormone across the placenta. This is measured in umbilical cord
serum to be 25-50 percent of normal [10]. This provides a protective effect,
especially to the fetal brain [11]. Also, the most common form of congenital
hypothyroidism has some moderately functioning thyroid tissue [12]. The slow
development of obvious clinical symptoms [13], coupled with the importance of
early treatment led to the implementation of widespread newborn screening for this
Table 4
Etiology of congenital hypothyroidism in 148 patients diagnosed in the Quebec
Newborn Screening program from 1990-2004. (modified from: Eugene et al. J
Clin Endocrinol Metab 90:2696-2700, 2005 [111])
Thyroid dysgenesis is generally thought to be sporadic in occurrence. However,
recent evidence points to the possibility of a genetic component. One study of all
cases of thyroid dysgenesis found that 2% were familial in occurrence [31].
Additional studies also showed that 7.9% of first degree relatives of infants with
congenital hypothyroidism had a thyroid developmental anomaly [32]. There was
some speculation as to a possible seasonal variation in the incidence of congenital
hypothyroidism; however, this topic is still under debate [33,34].
Some genes have been implicated as a cause of thyroid dysgenesis. However, these
generally account for a small number of cases [35]. These include paired box gene
eight (PAX8), TTF-2, NKX2.1 and NXK2.5 [22-25][36-39]. These encode for
transcription factors which are expressed both during thyroid embryogenesis and in
the normal functioning gland [29]. These transcription factors are also expressed in
other tissues of the developing fetus. Mutations in genes coding for these
transcription factors lead to distinct phenotypic syndromes which are linked to
their tissue expression [40]. These are described below (see Table Table55).
Table 5
Transcription factor gene mutations resulting in thyroid dysgenesis and associated
clinical findings
TTF-2 - a homozygous missense mutation in TTF-2 causes a genetic syndrome of
thyroid dysgenesis, choanal atresia, cleft palate and spiky hair [22]. This syndrome
has been recently referred to as Bamforth-Lazarus Syndrome [35].
NKX2.1 - mutations in NKX2.1, also known as TTF-1, have been associated with
congenital hypothyroidism, respiratory distress and ataxia [23,24]. Also, recent
reports describe an NKX2.1 mutation with congenital hypothyroidism and benign
chorea [25,38].
NKX2.5 has
been
expressed
in
cardiac
tissues;
the
recent
finding
the
increased
hypothyroidism[39].
incidence
of
cardiac
malformations
in
congenital
Thyroid dyshormonogenesis
Hereditary defects in virtually all the steps of thyroid hormone biosynthesis and
secretions have been described and account for 10-15% of permanent congenital
hypothyroidism. These are generally transmitted in an autosomal recessive manner,
recently,
mutations
in
the
enzyme
dual
oxidase
(known
total or partial iodide organification defects [48]. Mutations in the dual oxidase
maturation factor (DUOXA2) gene also lead to deficient iodide organification
through similar mechanisms and can cause partial iodide organification defects
[49]. Other, rare causes of dyshormonogenesis include defects in sodium/iodide
transport, resulting from a mutation in the gene encoding the sodium-iodide
symporter [50], and defective thyroglobulin action, resulting from a mutation in the
gene encoding thyroglobulin [51]. A defect in the enzyme iodotyrosine deiodinase
which aids in the peripheral conversion of T4 to T3 has been shown in hypothyroid
individuals.
This
can
be
due
to
homozygous
mutations
in
the
pituitary
hormones
are
often
deficient,
including
growth
hormone,
Circulating T3 and T4 are mildly elevated without suppression of TSH. Thus these
infants are usually not detected by newborn screening [55].
.
Transient congenital hypothyroidism
Transient congenital hypothyroidism is found to be more common in Europe
(1:100) than the United States (1:50,000) [3]. In a report of over twenty years in
the French newborn screening program, the incidence of transient congenital
hypothyroidism was found to be 40 percent [3]. Causes of transient congenital
hypothyroidism include:
Iodine deficiency - Iodine deficiency is more common in European countries,
especially in preterm infants; this is due mainly to maternal iodine deficient diets
[3,12,56].
Transfer of maternal blocking antibodies - Maternal antithyroid antibodies can
cross the placenta and block the TSH receptor in the neonatal thyroid. This effect
can last up to 3 to 6 months after birth as maternal antibody levels fall [57,58].
Fetal exposure to antithyroid drugs - Maternal antithyroid drugs can cause
decreased neonatal thyroid hormone synthesis which lasts for a few days to two
weeks after birth.
Diagnosis
In those countries with newborn screening programs in place, essentially all infants
with congenital hypothyroidism are diagnosed after detection by newborn
screening tests. Screening programs have been developed in Canada, the United
States, parts of Mexico, Western Europe, Japan, Australia, New Zealand, and
Israel, and they are under development in parts of many countries in Eastern
Europe, Asia, South America and Africa. Of the worldwide birth population of 127
million, it is estimated that 25 percent undergo screening for congenital
hypothyroidism. In infants born in locations without newborn screening programs,
diagnosis may be made after development of clinical manifestations of
hypothyroidism.
.
Newborn thyroid screening tests
The specimen used for newborn screening tests is blood from a heel-prick
collected on special filter paper cards. The specimen is routinely collected between
two and five days of age (or at discharge from the hospital, if this occurs earlier);
some programs use cord blood for screening. In addition, some programs also
routinely obtain a 2 nd specimen between two and six weeks of age. The filter paper
cards are then sent to a centralized laboratory for testing. Early in the experience of
screening, most programs undertook an initial T4 test, with a follow-up TSH test
on infants below a specified T4 cutoff [2]. With increasing accuracy of TSH
measurement, many screening programs now carry out an initial TSH test to detect
congenital hypothyroidism. Each program must develop its own T4 and TSH
cutoff for recall of infants with abnormal test results (see Figure Figure4,4,
Diagnostic algorithm). As there are rapid changes in TSH and T4 in the first few
days of life, many programs have developed age-related cutoffs. Following are
examples of typical cutoffs for T4 and TSH:
Figure 4
Congenital hypothyroidism: Diagnostic algorithm. Diagnostic algorithm: the
diagnosis of congenital hypothyroidism begins with either abnormal newborn
screening test results or a clinical suspicion of hypothyroidism, leading to serum
thyroid function tests ...
Initial T4 < 10 th percentile follow-up TSH test
Initial TSH > 30 mU/L serum (> 15 mU/L whole blood)); some programs use an
upper percentile TSH cutoff, e.g., > 97 th percentile
Both of the above screening test approaches will detect the majority of infants with
primary congenital hypothyroidism. There are some advantages and disadvantages
with each approach in the detection of other thyroid disorders. Both screening test
approaches do a good job of detecting infants with primary CH. The primary T4follow-up TSH test strategy will detect some infants with secondary or central
(hypopituitary) hypothyroidism and infants with "delayed TSH rise". On the other
hand, a primary TSH test strategy will detect infants with mild or "subclinical"
hypothyroidism (see Table Table6).6). Neither test approach will detect infants
with defects of thyroid transport, metabolism, or action. With a goal of detecting
all of these thyroid disorders, some programs have undertaken pilot programs
measuring both T4 and TSH on all newborns. These programs tend to report a
higher incidence of congenital hypothyroidism [63].
Table 6
A comparison of the thyroid disorders detected by primary T4-follow-up TSH
testing vs. primary TSH testing
.
Table 7
Reference ranges for thyroid function tests at ages 1-4 days and 2-4 weeks [64]
The finding of an elevated serum TSH level and a low free T4 or total T4 confirms
the diagnosis of primary hypothyroidism. The finding of an elevated serum TSH
with a normal free T4 or total T4 is consistent with subclinical primary
hypothyroidism. Because of the dependence of the developing brain on optimal
concentrations of thyroid hormone, we recommend treating infants with subclinical
hypothyroidism.
It is now recognized that preterm infants or acutely ill term infants with primary
hypothyroidism may not show an elevated TSH level on the 1 st screening test.
Thus, many programs undertake a routine 2 ndscreening test in preterm and acutely
ill term infants. Such testing leads to the detection of infants with "delayed TSH
rise", which occurs in approximately 1:18,000 newborns [64].
Those programs that undertake a primary T4 test and recall infants with
persistently low T4 screening levels, e.g. on the routine 1 st and 2 nd specimens
(without elevated TSH levels) detect some infants with secondary or central
hypothyroidism [65]. Confirmatory serum testing will show a low free T4 or total
T4, with either a low TSH or an "inappropriately normal" TSH level. In infants
with central hypothyroidism, the TSH deficiency may be isolated, as in infants
with TSH gene mutations. In most cases of central hypothyroidism, however,
TSH deficiency is associated with other pituitary hormone deficiencies. Such
infant should be investigated for other pituitary hormone deficiencies, particularly
these tests will usually separate transient from permanent cases. If a familial form
of congenital hypothyroidism is discovered, this will guide genetic counseling. As
gene mutations have now been reported for virtually all steps in thyroid hormone
synthesis, the above diagnostic studies may lead to a specific genetic test to
confirm the underlying etiology. In addition, these diagnostic studies may be
performed routinely in programs that use this information for clinical
investigations. However, these diagnostic studies generally do not alter the
treatment decision, and so they are considered optional.
Table 8
Findings in diagnostic studies undertaken to identify the underlying etiology of
congenital hypothyroidism
.
Prevalence of NTDs in the United States has been estimated at 7 per 10,000
Pregnancies (Spina bifida Association America). Approximately 3,000 pregnancies
are affected by NTDs in the United States each year and every women who can
become pregnant is at risk for an NTD affected pregnancy. Epidemiologist reveal
the prevalence data in US are 1 in 1000 births in the US ( not including occulta
defects) Anencephaly 3 to 7 in 10,000; Eacencephaly 1.4 in 10,000 ; Spina bifida
5.5 In 10,000; Meningocele 2 to 4 10,000.
16
Prevalence of NTD from different parts of India was reported to vary from
3.9 to 11/1000 births and more so in the northern states (Punjab, Haryana, Delhi,
Rajasthan, U.P, Bihar) (3.9-9.0 per /1000 births) compared to eastern, western
(5.0/1000 and southern part (<5.0/1000) of India. (2009). 21
The prevalence of NTDs among consanguineous and non consanguineous
marriage was 6.3-20.6/1000 and 5.9-8.4/1000 couple respectively. 17
The Centers for Disease Control and Prevention estimates that the birth
rates in 2005 for 2 of the most common neural tube defects, Spina bifida and
anencephaly, were 17.96 and 11.11 per 100 000 live births, respectively . 18
Reproductive and Child health (RCH) programme stressed importance of
folic acid in periconceptional period for the prevention of Neural tube defect. Dose
for the primary prevention is 0.4 mcg of folic acid per day. 19
33
become pregnant and without a history of neural tube defects, the American
Academy of Family Physicians (AAFP) strongly recommends prescribing folic
acid supplementation of 0.4 to 0.8 mg/d. The AAFP also recommends prescribing
0.4 mg of folate supplementation to a woman of childbearing age if she is not
planning a pregnancy. The American College of Obstetrics and Gynecology, AAFP,
and most other organizations recommend 4 mg/d for women with a history of
neural tube defects. 21
The study result that nonpregnant female participants from age 15 to 49
years, indicate that 8 percentage of women consumed 400 g/d or more of folic
acid from fortified foods, and 26 percentage of women took 400 g/d or more of
folic acid through supplements within the previous month. Therefore, 34.3
percentage of women of reproductive age consumed 400 g/d or more through a
combination of fortified foods and supplements. 25
The study reported that the success of a 45 minute presentation among
female college student about Periconceptional nutrition and prevention NTD to
increasing knowledge about folic acid and NTD, raising scores on pretest to
posttest from 48 percentage correct to 86 percentage correct .One month following
the intervention, follow-up posttest score were still higher than the pretest.
Education to female student on prevention of neural tube defect in
From above fact the investigator understood that the inadequate intake of
folic acid ,Vitamin B , B12 , Zinc and Calcium etc in periconceptional period lead
to neural tube defects. There fore researcher has chosen this topic to assess the
knowledge of the female student regarding the prevention of Neural tube defect in
periconceptional period to promote awareness among the female student by
providing planned teaching programme.
REVIEW OF LITERATURE:
Review of literature involve the selection of available documents on the
topic , which contain information , ideas and data and evidence written from a
particular stand point to fulfill certain aims or express certain views o the nature of
the topic and how is to be investigated and the effective evaluation on these
documents in relation to the research being proposed.
The literature review was based on extensive survey of publisher and
unpublished research studies, journal articles and non-research literature related to
the present study.
The review of literature is presented in the following order:
1
5
6
prevention
NTDs are serious birth defects of the brain and spine. There are two
common forms of NTDs, anencephaly and spinal bifida, which account for 90
percentage of all cases (Centers for Disease Control 2000), NTDs occur very early
in pregnancy, between 18 and 28 days post ovulation, often before a women knows
that she is pregnant. 24
The defect occurs when the Neural tube, which later becomes the brain
and spine, does not form or close completely. Anencephaly the condition that
results when the upper end of the Neural tube does not close completely and the
brain and the skull are missing or under developed is a fatal birth defect. (Seilet
2006) .The Spina bifida Association of America estimates that there are 70,000
people currently living with Spina bifida is the United State .24
There are two types of NTDs. The most common are called open type
NTDs, Open NTDs are occur when the brain and / or Spinal cord are exposed at
birth through a defect in the skull or vertebrae (back bone). E.g. of the open NTDs
are Spina bifida (myelomeningocele), Anencephaly and Enencephalocele. 25
Rare type of NTDs is called closed NTDs. Closed NTDs occur when the
Spinal bifida is covered by skin. Common examples of closed NTDs are
Lipomyelo-meningocele and lipomeningocele.
two affected male. The frequency of neural tube malformations among all births ,
live or still births ,was found to be higher among female than the male. 27
A study reported that the highest frequency of NTD was observed in North
India, in Amritsar, Chandigarh, Delhi, Japer, Udaipur and Ajmer. The combined
rate for anencephaly and Spina bifida was greater than 0.5 per/1000 births. The
high frequency was compared to the rate observed among the high risk
communities in the world like the Irish and Egyptains, and the author reported that
these defect are low among Negros and Mongolians .In USA and Japan showed
that the incidence of NTD was 9.6 and 9.0 per 1000 among spontaneous abortions
and therapeutic abortion respectively as against to 2.0 per 1000 at births .the rate
was less than this for all the Centers in south India except for Davangere,
Hyderabad and Pandichery.
28
1.09 per 1000 live births, the male to female ratio 2:1 and the increase in the
incidence is attributed to cansanguinity which was found to be in 89% of the Spina
Bifida parents as compared with the 67% of the control. 30
A study reported 25% of the 64 mother were on folate supplementing during
affected pregnancy, to prove that the NTD is closely related to folic acid defiency.
Double blind randomized trial of Medical Research Council, Great Britain shows
that supplementation of 5mg per day for at least one month prior to conception to 3
months post conception reduce the risk of reoccurrence of NTD by 70% .31
4. Studies related to prevention of neural tube defect in periconceptional
period.
A case control study on neural tube defect of neonate and folic acid
awareness .and conducted
period 14,580 live births took place at GH Kandy and twenty of them had NTDs.
The number of babies with NTDs transferred from other hospitals was 30. The
control group comprised 150 mothers with normal babies. Fourteen (28%) of the
affected group were able to idenyify folic acid tablet as a vitamin taken during
pregnancy, in comparison to 87 (58%) of the control group. One (2%) from the
affected group and 70 (46%) from the control group knew about the value of preconceptional FA .None of the affected mothers had used FA pre-conceptionaly
where as 54 (26%) of the control group mother believed that folic acid helped in
preventing birth defects. 31
A prospective study, conducted at M G H Medical College and My
Hospital, Indore M P between October 2008- 2009. Total 52 cases of Spina bifida
admitted in the hospital were evaluated about maternal antenatal history, folic acid
intake, birth order, family history & socio-economic status. Out of the total 52
cases, 20 belong to 2nd birth order, 16 belong to 1st birth order, 10 belong to 3rd
birth order, 5 belong to 4th birth order & 1 belong to 5th birth order. Maternal folic
acid intake was not found in all cases during preconception & 1st month of
gestation. Two mothers gave history of viral fever during 2nd month of gestation.
Family history was not found in any case. All except 2 cases belong to low socioeconomic status.
32
conducted. Of 387 women (mean age: 18 1.9 years), 72% were black and 28%
were Hispanic. At enrollment, clinics were a major source of information of NTD
prevention (44%); 52% had heard of folic acid, 45% had heard of NTDs, and 50%
had heard of birth defects prevention by multivitamins. Significantly more
Hispanic than black young women had heard of NTDs (59% vs. 39%). Pregnancy
history, regular birth control use, and education level for age were independently
associated with knowledge. In young women with low education level for age,
regular birth control use was significantly associated with knowledge. At
enrollment, daily multivitamin intake was very low (9%) and folate-rich foods
were consumed in inadequate amounts. Adequate folate diet was not associated
with knowledge. The program follow-up survey indicated that 88% to 92% had
knowledge of NTDs and folic acid, and 67% reported taking a daily multivitamin.
Preliminary evidence suggests that a promotion program improves knowledge, and
dispensing of multivitamins increases multivitamin use. 37
A study was conducted to ascertain knowledge of periconceptional folate
for prevention of neural tube defect (NTD) and to estimate folate intake in young
women. Three hundred young women were questioned about their knowledge of
folate for prevention of NTD. Their folate intake was assessed by food frequency
questionnaire. Fourteen per cent of 1619 year olds and 41% of undergraduates
were aware of the need to increase folate intake before conception. Median folate
intake was estimated to be 235 g/day in 1619 year olds and 248.5 g/day in
undergraduates. More than a quarter of women in both groups had folate intakes
less than the reference nutrient intake (RNI) (200 g/d) below which prevalence of
NTD rises dramatically and these women would therefore be at increased risk of
having a child with NTD should they have an unplanned pregnancy. Strategies are
required to increase folate intake among young women and inform them of the
benefit of periconceptional folate supplementation. 38
METHODOLOGY
STATEMENT OF THE PROBLEM:
A study on effectiveness of planned teaching programme on prevention
of Neural tube defect in periconceptional period among female student at selected
college in Bangalore.
HYPOTHESIS:
H 1:
H 2:
anomalies and imply a failure of proper closure of neural tube and covering
mesoderm and ectoderm.
Periconceptional period: Periconceptional period is period start from first three
month before conception and after three month of conception.
ASSUMPTIONS:
1. Female student have inadequate knowledge on prevention of neural tube
defect in periconceptional period.
2. Socio demographic variables influence the level of knowledge of the female
student regarding prevention of Neural tube defect in periconceptional
period.
3. Mass media influences the level of female student regarding prevention of
neural tube defect in periconceptional period.
SAMPLING CRITERIA:
Inclusion criteria:
1.
2.
3.
4.
Exclusion criteria:
1.
DISCUSSION
Congenital malformations have been known and recognized for countries. It is an
estimating problem for research because of the high frequency of their occurrence
and the devastating effect they may have on the individual and his/her family.
Central nervous system anomalies are such anomalies which account for the higher
mortality among the newborn.11
There have been large variations in the incidence of central nervous system
defects in different parts of the World and at different periods. Neural tube defects
are malformations of the developing brain and spinal cord occurring during the
third to fourth week of gestation. 16
Neural tube defects top the list of birth defects in India contributing to both
morbidity and Mortality.12
World health organization (WHO) / United Nations Administrative
Committee on Nutrition stated that Iron and Folic acid deficiency affects more than
3.5 billion people in developing world. In developed countries the prevalence are
about 18 percentage in pregnant women and 12 percentage in non pregnant
women. 19
are affected by NTDs in the United States each year and every women who can
become pregnant is at risk for an NTD affected pregnancy. Epidemiologist reveal
the prevalence data in US are 1 in 1000 births in the US ( not including occulta
defects) Anencephaly 3 to 7 in 10,000; Eacencephaly 1.4 in 10,000 ; Spina bifida
5.5 In 10,000; Meningocele 2 to 4 10,000.
16
Prevalence of NTD from different parts of India was reported to vary from
3.9 to 11/1000 births and more so in the northern states (Punjab, Haryana, Delhi,
Rajasthan, U.P, Bihar) (3.9-9.0 per /1000 births) compared to eastern, western
(5.0/1000 and southern part (<5.0/1000) of India. (2009). 21
The prevalence of NTDs among consanguineous and non consanguineous
marriage was 6.3-20.6/1000 and 5.9-8.4/1000 couple respectively. 17
The Centers for Disease Control and Prevention estimates that the birth
rates in 2005 for 2 of the most common neural tube defects, Spina bifida and
anencephaly, were 17.96 and 11.11 per 100 000 live births, respectively . 18
Reproductive and Child health (RCH) programme stressed importance of
folic acid in periconceptional period for the prevention of Neural tube defect. Dose
for the primary prevention is 0.4 mcg of folic acid per day. 19
Folic acid also known as folate is a B vitamin (B9) found in leafy
vegetables like spinach, kale, orange juice and whole grains. Taking 400
CONCLUSION
A study was conducted to assess the knowledge of neural tube defect (NTD)
prevention by folic acid and periconceptional practices in young women. Young
minority women were enrolled in a folic acid program at 3 urban Houston, Texas,
reproductive health clinics and assessed for NTD knowledge and preventive
practices. A 3-month supply of multivitamins was also dispensed at enrollment. A
3-month program follow-up survey of a randomly selected sample at 2 sites was
conducted. Of 387 women (mean age: 18 1.9 years), 72% were black and 28%
were Hispanic. At enrollment, clinics were a major source of information of NTD
prevention (44%); 52% had heard of folic acid, 45% had heard of NTDs, and 50%
had heard of birth defects prevention by multivitamins. Significantly more
Hispanic than black young women had heard of NTDs (59% vs. 39%). Pregnancy
history, regular birth control use, and education level for age were independently
associated with knowledge. In young women with low education level for age,
regular birth control use was significantly associated with knowledge. At
enrollment, daily multivitamin intake was very low (9%) and folate-rich foods
were consumed in inadequate amounts. Adequate folate diet was not associated
with knowledge. The program follow-up survey indicated that 88% to 92% had
knowledge of NTDs and folic acid, and 67% reported taking a daily multivitamin.
SUMMARY
Congenital hypothyroidism (CH) is defined as thyroid hormone deficiency present
at birth. Thyroid hormone deficiency at birth is most commonly caused by a
problem with thyroid gland development (dysgenesis) or a disorder of thyroid
hormone biosynthesis (dyshormonogenesis). These disorders result in primary
hypothyroidism. Secondary or central hypothyroidism at birth results from a
deficiency of thyroid stimulating hormone (TSH). Congenital TSH deficiency may
rarely be an isolated problem (caused by mutations in the TSH subunit gene), but
most commonly it is associated with other pituitary hormone deficiencies, as part
of congenital hypopituitarism. Peripheral hypothyroidism is a separate category
resulting from defects of thyroid hormone transport, metabolism, or action.
Congenital hypothyroidism is classified into permanent and transient CH.
Permanent CH refers to a persistent deficiency of thyroid hormone that requires
life-long treatment. Transient CH refers to a temporary deficiency of thyroid
hormone, discovered at birth, but then recovering to normal thyroid hormone
production. Recovery to euthyroidism typically occurs in the first few months or
years of life. Permanent CH can be further classified into permanent primary and
secondary (or central) CH; transient primary CH has also been reported. In
addition, some forms of CH are associated with defects in other organ systems;
these are classified as syndromic hypothyroidism.
BIBLIOGRAPHY
REFERENCES
Alm J, Larsson A, Zetterstrom R. Congenital hypothyroidism in Sweden. Incidence
and age at diagnosis. Acta PaediatrScand. 1978;67(1):13. doi: 10.1111/j.16512227.1978.tb16268.x. [PubMed] [Cross Ref]
Fisher DA. Second International Conference on Neonatal Thyroid Screening:
progress
report.
JPediatr.
1983;102(5):653654.
doi:
10.1016/S0022-
results
of
the
neonatal
screening
program
1990-2000.
Abu EO, Bord S, Horner A, Chatterjee VK, Compston JE. The expression of
thyroid hormone receptors in human bone. Bone. 1997;21(2):137142. doi:
10.1016/S8756-3282(97)00097-5. [PubMed]